Finance
FDA Speeds Drug Reviews, Approves Therapies in Record Time
The FDA is dramatically speeding up drug reviews with a new priority program, leading to approvals in record time, sometimes within 60 days. This initiative aims to bring life-changing therapies to patients faster by cutting red tape and streamlining processes, without compromising safety. The agency is also tackling issues like illegal marketing of compounded drugs and improving drug safety reporting.
